Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Big Pharma
JNJ
AbbVie
Pfizer
Roche
Eli Lilly
Novo Nordisk
Merck
FDA says all doses of Lilly's weight-loss and diabetes drug are now available
Reuters
Sun, 08/4/24 - 06:44 pm
Eli Lilly
FDA
Zepbound
Mounjaro
drug shortages
Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports
Reuters
Thu, 08/1/24 - 11:13 pm
Eli Lilly
weight loss
Zepbound
drug shortages
Lilly says weight loss drug cuts heart failure risk by 38% in trial
Reuters
Thu, 08/1/24 - 11:08 am
Eli Lilly
Zepbound
heart failure
Inside Eli Lilly’s multi-year Team USA partnership
Medical Marketing and Media
Wed, 07/24/24 - 11:51 am
Eli Lilly
Olympics
branding
pharma marketing
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
BioSpace
Mon, 07/22/24 - 06:50 pm
Innovent Biologics
mazdutide
obesity
China
Eli Lilly
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers
Yahoo/Raleigh News & Observer
Mon, 07/22/24 - 06:48 pm
Novo Nordisk
Eli Lilly
obesity
Wegovy
Zepbound
North Carolina
Medicaid
Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout
Fierce Biotech
Fri, 07/19/24 - 11:54 am
Morphic
Eli Lilly
M&A
Eli Lilly's weight loss drug tirzepatide gets approval in China
Reuters
Fri, 07/19/24 - 11:45 am
Eli Lilly
tirzepatide
China
A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill
Pharma Voice
Thu, 07/18/24 - 11:12 am
Ensho Therapeutics
IBD
Gilead Sciences
Eli Lilly
As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them
Stat
Wed, 07/17/24 - 11:39 am
Novo Nordisk
Eli Lilly
diabetes
insulin
patients
Will Eli Lilly overtake Novo Nordisk in weight-loss drug race?
BioSpace
Tue, 07/16/24 - 12:11 pm
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
weight loss
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
Motley Fool
Mon, 07/15/24 - 09:53 am
Eli Lilly
Kisunla
FDA
Alzheimer's disease`
Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts
Fierce Pharma
Fri, 07/12/24 - 11:33 am
obesity
diabetes
oncology
Novo Nordisk
Eli Lilly
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Fri, 07/12/24 - 11:16 am
EMA
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Mounjaro
Zepbound
surgery
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study
BioSpace
Tue, 07/9/24 - 11:51 am
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
weight loss
FDA approval is just the beginning. Now Lilly’s Kisunla faces the tough Alzheimer’s market
Pharma Voice
Tue, 07/9/24 - 11:24 am
Eli Lilly
Kisunla
Alzheimer's disease
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing
BioSpace
Mon, 07/8/24 - 11:01 pm
Myricx Bio
funding
antibody-drug conjugate
Eli Lilly
Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster
Fierce Biotech
Mon, 07/8/24 - 11:54 am
Eli Lilly
Morphic
M&A
Takeda
Entyvio
IBD
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
BioSpace
Mon, 07/8/24 - 11:49 am
GLP-1
Ozempic
Novo Nordisk
Eli Lilly
obesity
cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »